Het consortium wordt gevormd door hDMT-onderzoekers en het is de bedoeling dat de OoC-modellen met geïntegreerde lymfevaten kunnen worden toegepast als precisie-instrument in de strijd tegen immuungerelateerde ziekten.

LymphChip consortium

Human disease and regenerative medicine models, including formats referred to as “organ-on-chip” (OoC), are increasingly regarded as powerful tools for drug discovery, safety pharmacology and efficacy testing, in both personalized and precision medicine. Developed over the past 10 years, they constitute an important new approach to medicine and towards the replacement of animal models. To date, however, OoC models lack the lymphatic and immune system, despite their essential role in health and disease.


We zijn blij te kunnen melden dat het LymphChip project nu officieel van start is gegaan.


Academic partners

  • Logo Amsterdam UMC
  • Logo WUR
  • Logo TU Delft
  • Logo Maastricht University
  • Logo LUMC
  • Logo AST

LymphChip Co-Financing Partners

  • logo Tissue GMBH
  • logo Proefdiervrij
  • logo Polyvation
  • Logo One Planet
  • Logo Nostics
  • Logo Ibidi
  • Logo IBA
  • Logo Nederlandse Brandwondenstichting
  • Logo Cealus Health
  • Logo HDMT
  • Logo Optics 11
  • Logo AIM Biotech

Cooperating Partners

  • Logo RIVM
  • Logo Danone Nutricia
  • Logo MLDS
  • logo AMC
  • logo The University of Melbourne
  • logo Ncardia
  • logo Utrecht University
  • Logo WUR

© Alle rechten voorbehouden



Project Manager:

Margot Beukers
Science Business Support 

Project management for life sciences research projects including training and advice


NWO-logo huisstijlsite

The LymphChip consortium is funded by the NWA-ORC programme of the Dutch Research Council
(NWO; project number 1292.19.019)